EUVIMEDEUVIMED entdecken
Crossref

DEVELOPMENT AND VALIDATION OF SAT-ANT: A SAFETY ASSESSMENT TOOL FOR ANTICOAGULANT THERAPY

Yogesh S Hikkanagutti, Anushree Deshpande, M S Ganachari, Vishwa Rajkumar Byakod

International Journal of Drug Delivery Technology · 02.07.2026 · 16 (61s)

DOI: 10.25258/ijddt.16.61s.53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.07.2026. Verfasst von Yogesh S Hikkanagutti und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation, deep vein thrombosis, pulmonary embolism, and acute coronary syndromes are among the thromboembolic illnesses that are commonly prevented and treated with anticoagulant therapy. Anticoagulant therapy has advantages, but it also has a high risk of adverse events, medication mistakes, and drug-related problems (DRPs), which emphasizes the need for a standardized safety evaluation technique.

Objective

To develop and validate Safety Assessment Tool (SAT-ANT) for patients receiving anticoagulant therapy. Methodology Over the course of eight months, a prospective observational study was carried out at a tertiary care hospital in the department of general medicine and cardiology. The study included 83 adult patients on anticoagulant therapy. Fifteen experts designed and validated the Anticoagulation Therapy Adherence Questionnaire (ATAQ) and the SAT-ANT. Cronbach's alpha was used to evaluate reliability. Using clinical information examined, including DRPs, serum creatinine, and INR.

Results

SAT-ANT demonstrated good reliability (Cronbach's alpha = 0.841), while ATAQ showed excellent reliability (Cronbach's alpha = 0.901). Most participants were males aged 20–60 years (62.7%). Enoxaparin sodium was the most frequently prescribed anticoagulant (43.4%). A total of 83 DRPs were identified, with dose-related problems being the most common (47.0%). Increased bleeding risk was the predominant adverse event. Warfarin overdose and warfarin–aspirin interaction were the most frequent DRPs. Most patients had elevated INR values & knowledge regarding anticoagulant therapy.

Conclusion

Pharmacist-led anticoagulation stewardship is supported by SAT-ANT, a dependable and clinically beneficial technique for detecting safety concerns in anticoagulant medication.

Zitieren

APA

Hikkanagutti, Y. S., Deshpande, A., Ganachari, M. S., & Byakod, V. R. (2026). DEVELOPMENT AND VALIDATION OF SAT-ANT: A SAFETY ASSESSMENT TOOL FOR ANTICOAGULANT THERAPY. International Journal of Drug Delivery Technology, 16(61s). https://doi.org/10.25258/ijddt.16.61s.53

Vancouver

Hikkanagutti YS, Deshpande A, Ganachari MS, Byakod VR. DEVELOPMENT AND VALIDATION OF SAT-ANT: A SAFETY ASSESSMENT TOOL FOR ANTICOAGULANT THERAPY. International Journal of Drug Delivery Technology. 2026;16(61s). doi:10.25258/ijddt.16.61s.53

BibTeX
@article{Hikkanagutti2026,
  author = {Hikkanagutti, Yogesh S and Deshpande, Anushree and Ganachari, M S and Byakod, Vishwa Rajkumar},
  title = {DEVELOPMENT AND VALIDATION OF SAT-ANT: A SAFETY ASSESSMENT TOOL FOR ANTICOAGULANT THERAPY},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {61s},
  doi = {10.25258/ijddt.16.61s.53}
}
Kostenlos starten →